Quince Therapeutics, Inc. (QNCX) › Shares OutstandingQuince Therapeutics, Inc. (QNCX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 3.41M2019: 26.87M2020: 29.54M2021: 30.07M2022: 36.14M2023: 42.97M2024: 44.00M2025: 55.73M55.73M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202555.73M+26.6%202444.00M+2.4%202342.97M+18.9%202236.14M+20.2%202130.07M+1.8%202029.54M+10.0%201926.87M+687.4%20183.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share